Terms: = Breast cancer AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246
402 results:
1. Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).
Hawranek C; Ehrencrona H; Öfverholm A; Hellquist BN; Rosén A
Trials; 2023 Dec; 24(1):810. PubMed ID: 38105176
[TBL] [Abstract] [Full Text] [Related]
2. Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer.
Liu Z; Yu B; Su M; Yuan C; Liu C; Wang X; Song X; Li C; Wang F; Ma J; Wu M; Chen D; Yu J; Yu Z
BMC Med; 2023 Dec; 21(1):493. PubMed ID: 38087296
[TBL] [Abstract] [Full Text] [Related]
3. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
[No Abstract] [Full Text] [Related]
4. Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary breast and Ovarian cancer.
Desai NV; Barrows ED; Nielsen SM; Hatchell KE; Anderson MJ; Haverfield EV; Herrera B; Esplin ED; Lucassen A; Tung NM; Isaacs C
JCO Precis Oncol; 2023 Aug; 7():e2200695. PubMed ID: 37535880
[TBL] [Abstract] [Full Text] [Related]
5. Uncommon variants detected via hereditary cancer panel and suggestions for genetic counseling.
Özdemir Z; Çevik E; Öksüzoğlu ÖBÇ; Doğan M; Ateş Ö; Esin E; Bilgetekin İ; Demirci U; Köseoğlu Ç; Topal A; Karadurmuş N; Erdem HB; Bahsi T
Mutat Res; 2023; 827():111831. PubMed ID: 37453313
[TBL] [Abstract] [Full Text] [Related]
6. Hereditary Gastric cancer: Single-Gene or Multigene Panel Testing? A Mono-Institutional Experience.
Calvello M; Marabelli M; Gandini S; Marino E; Bernard L; Dal Molin M; Di Cola G; Zanzottera C; Corso G; Fazio N; Gervaso L; Fumagalli Romario U; Barberis M; Guerrieri-Gonzaga A; Bertario L; Serrano D; Bonanni B
Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239438
[TBL] [Abstract] [Full Text] [Related]
7. Risk of Syndrome-Associated cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants.
Chen X; Meyer MA; Kemppainen JL; Horibe M; Chandra S; Majumder S; Petersen GM; Rabe KG
JAMA Oncol; 2023 Jul; 9(7):955-961. PubMed ID: 37200008
[TBL] [Abstract] [Full Text] [Related]
8. Mismatch repair-deficient glioma with spatially distinct IDH-mutant and IDH-wild type components arising in the setting of Lynch syndrome.
Tan H; Nerison C; Stateler C; Bowden SG; Raslan AM; Ambady P; Barajas RF; Wood MD
Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 37076313
[TBL] [Abstract] [Full Text] [Related]
9. Pilot study of gene mutations associated with Lynch syndrome in Slovak patients with breast cancer.
Krasničanová L; Saade R; Priščáková P; Gbelcová H; Kaľavská K; Karaba M; Benca J; Mego M; Repiská V
Klin Onkol; 2023; 36(2):130-134. PubMed ID: 37072247
[TBL] [Abstract] [Full Text] [Related]
10. Patterns of care and outcomes of risk reducing surgery in women with pathogenic variants in non-BRCA and Lynch syndrome ovarian cancer susceptibility genes.
Schwartz ZP; Li AJ; Walsh CS; Rimel BJ; Alvarado MM; Lentz SE; Cass I
Gynecol Oncol; 2023 Jun; 173():1-7. PubMed ID: 37030072
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive profiling of pathogenic germline large genomic rearrangements in a pan-cancer analysis.
Sun Z; Bai C; Su M; Tang H; Wu X; Wang Y; Bao H; Liu X; Wu X; Shao Y; Xu B
Mol Oncol; 2023 Sep; 17(9):1917-1929. PubMed ID: 37013911
[TBL] [Abstract] [Full Text] [Related]
12. Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception.
Bychkovsky BL; Lo MT; Yussuf A; Horton C; Hemyari P; LaDuca H; Garber JE; Scheib R; Rana HQ
Breast Cancer Res Treat; 2023 Jul; 200(1):63-72. PubMed ID: 36856935
[TBL] [Abstract] [Full Text] [Related]
13. Identification of Germline Variants in Patients with Hereditary cancer Syndromes in Northeast Mexico.
Pérez-Ibave DC; Garza-Rodríguez ML; Noriega-Iriondo MF; Flores-Moreno SM; González-Geroniz MI; Espinoza-Velazco A; Castruita-Ávila AL; Alcorta-Núñez F; Zayas-Villanueva OA; González-Guerrero JF; Alcorta-Garza A; Vidal-Gutiérrez O; Burciaga-Flores CH
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833268
[TBL] [Abstract] [Full Text] [Related]
14. Management of patients with presumed germline pathogenic variant from tumor-only genomic sequencing: A retrospective analysis at a single facility.
Kawamura M; Shirota H; Niihori T; Komine K; Takahashi M; Takahashi S; Miyauchi E; Niizuma H; Kikuchi A; Tada H; Shimada M; Kawamorita N; Kanamori M; Sugiyama I; Tsubata M; Ichikawa H; Yasuda J; Furukawa T; Aoki Y; Ishioka C
J Hum Genet; 2023 Jun; 68(6):399-408. PubMed ID: 36804482
[TBL] [Abstract] [Full Text] [Related]
15. Frequency of Pathogenic Germline Mutations in Early and Late Onset Familial breast cancer Patients Using Multi-Gene Panel Sequencing: An Egyptian Study.
Nassar A; Zekri AN; Kamel MM; Elberry MH; Lotfy MM; Seadawy MG; Hassan ZK; Soliman HK; Lymona AM; Youssef ASE
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672847
[TBL] [Abstract] [Full Text] [Related]
16. Occurrence of variants of unknown clinical significance in genetic testing for hereditary breast and ovarian cancer syndrome and Lynch syndrome: a literature review and analytical observational retrospective cohort study.
Adam F; Fluri M; Scherz A; Rabaglio M
BMC Med Genomics; 2023 Jan; 16(1):7. PubMed ID: 36647026
[TBL] [Abstract] [Full Text] [Related]
17. Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations.
Kim J; Jeong K; Jun H; Kim K; Bae JM; Song MG; Yi H; Park S; Woo GU; Lee DW; Kim TY; Lee KH; Im SA
Hum Genomics; 2023 Jan; 17(1):2. PubMed ID: 36604691
[TBL] [Abstract] [Full Text] [Related]
18. Strong Hereditary Predispositions to Colorectal cancer.
Hryhorowicz S; Kaczmarek-Ryś M; Lis-Tanaś E; Porowski J; Szuman M; Grot N; Kryszczyńska A; Paszkowski J; Banasiewicz T; Pławski A
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553592
[TBL] [Abstract] [Full Text] [Related]
19. Corded and hyalinized endometrioid endometrial carcinoma with high-grade features: a clinicopathological and TCGA-based molecular analysis.
Travaglino A; Arciuolo D; Santoro A; Raffone A; Pedone Anchora L; Piermattei A; Martinelli M; Mollo A; Onori ME; Minucci A; Inzani F; Fanfani F; Insabato L; Zannoni GF
Virchows Arch; 2023 Apr; 482(4):671-678. PubMed ID: 36550216
[TBL] [Abstract] [Full Text] [Related]
20. cancer prevention in cancer predisposition syndromes: A protocol for testing the feasibility of building a hereditary cancer research registry and nurse navigator follow up model.
Etchegary H; Pike A; Puddester R; Watkins K; Warren M; Francis V; Woods M; Green J; Savas S; Seal M; Gao Z; Avery S; Curtis F; McGrath J; MacDonald D; Burry TN; Dawson L
PLoS One; 2022; 17(12):e0279317. PubMed ID: 36548287
[TBL] [Abstract] [Full Text] [Related]
[Next]
